Analyst Consensus
- Current Price
- 103.89 $
- Target (Low)
- 77.00 $
- Target (Mean)
- 129.67 $
- Target (High)
- 164.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 29
Recommendation Distribution
Recommendation Distribution| Strong Buy | 6 |
|---|
| Buy | 21 |
|---|
| Hold | 2 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 11.5%
- Operating Margin
- 15.5%
- Gross Margin
- 37.2%
- Return on Equity (ROE)
- 11.0%
- Return on Assets (ROA)
- 4.4%
- Revenue Growth
- 6.5%
- Earnings Growth
- -29.8%
- Debt/Equity
- 41.07
- Current Ratio
- 0.68
- Beta
- 1.39
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 12, 2026 | Needham | Buy → Buy |
| Jun 5, 2026 | Rosenblatt | Buy → Buy |
| May 8, 2026 | Citigroup | Buy → Buy |
| May 7, 2026 | JP Morgan | Overweight → Overweight |
| May 7, 2026 | Barclays | Overweight → Overweight |
| May 7, 2026 | Guggenheim | Buy → Buy |